BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8791988)

  • 1. Comparison of the effect of different inhibitors of the non-enzymatic glycation of rat tail tendons and bovine serum albumin.
    Menzel EJ; Reihsner R
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():241-8. PubMed ID: 8791988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of biochemical and biomechanical properties of rat tail tendons caused by non-enzymatic glycation and their inhibition by dibasic amino acids arginine and lysine.
    Menzel EJ; Reihsner R
    Diabetologia; 1991 Jan; 34(1):12-6. PubMed ID: 1905245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of L-arginine on biomechanical parameters of native and nonenzymatically glycated rat tail tendons.
    Reihsner R; Menzel EJ
    Connect Tissue Res; 1994; 31(1):55-65. PubMed ID: 15609622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats.
    Kochakian M; Manjula BN; Egan JJ
    Diabetes; 1996 Dec; 45(12):1694-700. PubMed ID: 8922353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial behavior of aminoguanidine in the presence of either reducing sugars or soluble glycated bovine serum albumin.
    Serban AI; Costache M; Dinischiotu A
    Carbohydr Res; 2011 Dec; 346(18):2872-80. PubMed ID: 22063504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p-Dimethylaminobenzaldehyde-reactive substances in tail tendon collagen of streptozotocin-diabetic rats: temporal relation to biomechanical properties and advanced glycation endproduct (AGE)-related fluorescence.
    Stefek M; Gajdosik A; Gajdosikova A; Krizanova L
    Biochim Biophys Acta; 2000 Nov; 1502(3):398-404. PubMed ID: 11068182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats.
    Brennan M
    J Biol Chem; 1989 Dec; 264(35):20947-52. PubMed ID: 2592359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-mediated in vitro glycation modulates biomechanical integrity of the soft tissues but not hard tissues.
    Reddy GK
    J Orthop Res; 2003 Jul; 21(4):738-43. PubMed ID: 12798076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Advanced Glycation End Product Formation in Rat Tail Tendons by Polydatin and p-Coumaric acid: an In Vitro Study.
    Selvakumar G; Venu D; Kuttalam I; Lonchin S
    Appl Biochem Biotechnol; 2022 Jan; 194(1):339-353. PubMed ID: 34855112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus.
    Oxlund H; Andreassen TT
    Diabetologia; 1992 Jan; 35(1):19-25. PubMed ID: 1541376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo.
    Jung E; Kim J; Kim SH; Kim S; Cho MH
    Eur J Pharmacol; 2014 Dec; 744():98-102. PubMed ID: 25448307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
    Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.
    Fu MX; Wells-Knecht KJ; Blackledge JA; Lyons TJ; Thorpe SR; Baynes JW
    Diabetes; 1994 May; 43(5):676-83. PubMed ID: 8168645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro advanced glycation end product formation in rat tail tendon fibers: influence of aminoguanidine.
    Troncoso IA; Esteban MM; Ruiz MA; Flórez L; Barneo L
    Transplant Proc; 1995 Dec; 27(6):3345-6. PubMed ID: 8539985
    [No Abstract]   [Full Text] [Related]  

  • 15. L-Carnitine inhibits protein glycation in vitro and in vivo: evidence for a role in diabetic management.
    Rajasekar P; Anuradha CV
    Acta Diabetol; 2007 Jun; 44(2):83-90. PubMed ID: 17530472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit achilles tendon.
    Reddy GK
    Exp Diabesity Res; 2004; 5(2):143-53. PubMed ID: 15203885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of normal and in vitro aging by non-enzymatic glycation as verified by differential scanning calorimetry.
    Reihsner R; Pfeiler W; Menzel EJ
    Gerontology; 1998; 44(2):85-90. PubMed ID: 9523219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of green tea extract on advanced glycation and cross-linking of tail tendon collagen in streptozotocin induced diabetic rats.
    Babu PV; Sabitha KE; Shyamaladevi CS
    Food Chem Toxicol; 2008 Jan; 46(1):280-5. PubMed ID: 17884275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycation-induced matrix stability in the rabbit achilles tendon.
    Reddy GK; Stehno-Bittel L; Enwemeka CS
    Arch Biochem Biophys; 2002 Mar; 399(2):174-80. PubMed ID: 11888203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end-product cross-linking inhibits biomechanical plasticity and characteristic failure morphology of native tendon.
    Lee JM; Veres SP
    J Appl Physiol (1985); 2019 Apr; 126(4):832-841. PubMed ID: 30653412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.